Annexon, Inc. , a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders.
Annexon stock last closed at $1.68, up 15.07% from the previous day, and has decreased 63.04% in one year. It has overperformed other stocks in the Biotechnology industry by 0.15 percentage points. Annexon stock is currently +30.74% from its 52-week low of $1.29, and -78.6% from its 52-week high of $7.85.
As of Apr 21, 2025, there are 109.71M shares of ANNX outstanding. The market value of ANNX is $184.31M. In the last 24 hours, 3.6M ANNX shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy ANNX stock.
Based on our research, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, the next step is to fill out some personal details so you can invest in ANNX today.
Now that you have finished signing up on one of the best stock trading apps, you need to deposit funds:
Check out the tutorial below if you need help depositing funds into your brokerage account.
Once you have chosen the best place to buy Annexon stock, it's very important to research their stock prior to investing, so you truly wrap your head around the risk as well as the opportunity.
WallStreetZen was built to help everyday investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ANNX's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge ANNX's intrinsic value.
Using relative valuations metrics:
You can do additional valuation analysis on ANNX's stock here.
Out of 2 sell side analysts who give recommendations on ANNX, the consensus analyst rating on Annexon is a Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Annexon stock forecast page.
Over the last year, insiders at ANNX have bought more shares than they have sold.
Dean Richard Artis, EVP CHIEF SCIENTIFIC OFFICER of ANNX, was the latest ANNX insider to sell. They sold $16,379.55 worth of ANNX stock on Feb 18, 2025.
Dig into more about who owns ANNX shares here.
No, Annexon doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
You have two main options:
Hit the Open Trade button and eToro will place your order.
If you require more info about buying stocks on eToro, watch the helpful video below:
Now that you own some shares in ANNX, you'll want to stay up-to-date on your investment.
Make a watchlist to keep track of your ANNX stock.
To reiterate, here are the 6 steps to buy stock in Annexon:
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Annexon, create your watchlist below.